GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » BioNeutra Global Corp (TSXV:BGA) » Definitions » EPS (Diluted)

BioNeutra Global (TSXV:BGA) EPS (Diluted) : C$-0.06 (TTM As of Dec. 2023)


View and export this data going back to 1999. Start your Free Trial

What is BioNeutra Global EPS (Diluted)?

BioNeutra Global's Earnings per Share (Diluted) for the three months ended in Dec. 2023 was C$0.02. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was C$-0.06.

BioNeutra Global's EPS (Basic) for the three months ended in Dec. 2023 was C$0.02. Its EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2023 was C$-0.06.

BioNeutra Global's EPS without NRI for the three months ended in Dec. 2023 was C$0.02. Its EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2023 was C$-0.06.

During the past 3 years, the average EPS without NRIGrowth Rate was 13.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 13 years, BioNeutra Global's highest 3-Year average EPS without NRI Growth Rate was 180.20% per year. The lowest was -58.70% per year. And the median was 19.60% per year.


BioNeutra Global EPS (Diluted) Historical Data

The historical data trend for BioNeutra Global's EPS (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioNeutra Global EPS (Diluted) Chart

BioNeutra Global Annual Data
Trend Feb14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EPS (Diluted)
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.27 -0.08 -0.06 -0.06 -0.05

BioNeutra Global Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EPS (Diluted) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.02 -0.02 -0.03 -0.03 0.02

Competitive Comparison of BioNeutra Global's EPS (Diluted)

For the Packaged Foods subindustry, BioNeutra Global's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BioNeutra Global's PE Ratio Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, BioNeutra Global's PE Ratio distribution charts can be found below:

* The bar in red indicates where BioNeutra Global's PE Ratio falls into.



BioNeutra Global EPS (Diluted) Calculation

EPS (Diluted) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Diluted EPS takes into account all of the outstanding dilutive securities that could potentially be exercised (such as stock options and convertible preferred stock) and shows how such an action would impact earnings per share.

BioNeutra Global's Diluted EPS for the fiscal year that ended in Dec. 2023 is calculated as

Diluted EPS (A: Dec. 2023 ) = (Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(-2.108-0)/46.449
=-0.05

BioNeutra Global's Diluted EPS for the quarter that ended in Dec. 2023 is calculated as

Diluted EPS (Q: Dec. 2023 )=(Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(1.392-0)/35.826
=0.04

EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-0.06

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


BioNeutra Global  (TSXV:BGA) EPS (Diluted) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


BioNeutra Global EPS (Diluted) Related Terms

Thank you for viewing the detailed overview of BioNeutra Global's EPS (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.


BioNeutra Global (TSXV:BGA) Business Description

Traded in Other Exchanges
Address
9608 - 25 Avenue NW, Edmonton, AB, CAN, T6N 1J4
BioNeutra Global Corp is engaged in the research, development, production, and commercialization of food ingredients for neutraceutical, functional and mainstream foods, focusing on oligosaccharides. Its product portfolio provides ingredients for various food systems, that contribute to human nutrition and wellness in functional and healthy foods. Its prime product, VitaFiber IMO, is offered in both powder and syrup form. The company operates in Canada while generating sales revenue from various countries internationally. It has a single industry segment, manufacturing and trading of products. The majority of the revenue is derived from the United States.

BioNeutra Global (TSXV:BGA) Headlines

No Headlines